Immune-related Adverse Events (iraes) and Outcome in Recurrent/metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC) Patients (pts) Treated by Immune-Checkpoints Inhibitors (ICI)
Annals of Oncology（2019）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined